Imaz, ArkaitzLlibre, Josep MaríaNavarro Bernabé, JoanCurto, J. J. (Jorge Juan)Clotet, Bonaventura, 1953-Crespo, M.Murillo Rubio, ÓscarFerrer, ElenaSaumoy, MariaTiraboschi, Juan ManuelPodzamczer Palter, Daniel2018-11-272018-11-272012-11-11https://hdl.handle.net/2445/126488Purpose of the study: few clinical trials have compared non-nucleoside reverse transcriptase inhibitors (NNRTI) and ritonavir-boosted protease inhibitors (PI/r) as initial combined antiretroviral therapy (cART) for HIV-1-infected patients with high plasma viral load (pVL), and non-conclusive results have been reported. We compared the effectiveness between NNRTI and PI/r as first-line cART fof HIV-1-infected patients with high pVL.1 p.application/pdfengcc by (c) Imaz et al., 2012http://creativecommons.org/licenses/by/3.0/es/Infeccions per VIHAntiretroviralsHIV infectionsAntiretroviral agentsEffectiveness of first-line antiretroviral therapy based on NNRTIs vs ritonavir-boosted PIs in HIV-1 infected patients with high plasma viral loadinfo:eu-repo/semantics/article2018-07-24info:eu-repo/semantics/openAccess